Oxford Nanopore Technologies Ltd (ONT)

Currency in GBP
234.16
+14.16(+6.44%)
Closed·
Trading near 52-week High
ONT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
219.60238.80
52 wk Range
95.70238.80
Key Statistics
Bid/Ask
227.20 / 233.60
Prev. Close
220
Open
220
Day's Range
219.6-238.8
52 wk Range
95.7-238.8
Volume
5.73M
Average Volume (3m)
2.69M
1-Year Change
52.6467%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ONT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
201.18
Downside
-14.08%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

10 Buy
2 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 201.18
(-14.08% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
RBC Capital
Buy3.00+28.12%2.25MaintainSep 30, 2026
Citi
Buy2.50+6.76%2.10MaintainSep 28, 2026
Deutsche Bank
Buy2.10-10.32%1.95MaintainSep 22, 2026
Stifel
Hold1.50-35.94%1.25MaintainAug 28, 2026
Stifel
Hold1.50-35.94%1.25MaintainAug 28, 2026

Oxford Nanopore Technologies Ltd Earnings Call Summary for H1/2026

  • H1 2026 revenue rose 12.3% to £116.7M but missed targets due to China (-16%) and Middle East (-14%) weakness; stock surged 16% on margin gains.
  • Gross margin expanded 400bps to 62.2%; adjusted EBITDA loss halved to £22.1M from £48.3M, signaling improved operating leverage and cost discipline.
  • Maintained FY2026 guidance of 16-20% revenue growth; reaffirmed 2027 EBITDA breakeven and 2028 positive free cash flow targets despite revenue miss.
  • Secured £20M cross-licensing deal with diagnostics firm, plus £15M committed purchases through 2028 and long-term royalty stream representing 90% of deal value.
  • CEO Van Parys refocused strategy on high-value applications where technology has competitive edge; targeting £700M revenue and 15%+ EBITDA margin by 2030.
Last Updated: 2026-08-19, 08:52 a/m
Read Full Transcript

Earnings

Latest Release
Aug 19, 2026
EPS / Forecast
-0.05 / -0.07
Revenue / Forecast
116.7M / 122M
EPS Revisions
Last 90 days

ONT Income Statement

Compare ONT to Peers and Sector

Metrics to compare
ONT
Peers
Sector
Relationship
P/E Ratio
−17.7x−2.1x−0.3x
PEG Ratio
−1.03−0.060.00
Price/Book
5.1x4.8x2.6x
Price / LTM Sales
9.1x6.2x3.0x
Upside (Analyst Target)
−8.6%89.8%58.5%
Fair Value Upside
Unlock−13.2%7.1%Unlock

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA. The company offers MinION Mk 1D, a portable device for DNA and RNA sequencing; and GridION and GridION Q, a compact bench top device that delivers a version of hardware, software, and chemistry. It also provides PromethION products, such as PromethION 2, PromethION 24, and PromethION 48. The company has a collaboration with Cepheid to develop and commercialize automated infectious disease sequencing solutions. It operates in the region of Americas, Europe, the Middle East, Africa, India, and the Asia Pacific. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies plc in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is headquartered in Oxford, the United Kingdom.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
190.78M19.56%419.71M
Other Institutional Investors
692.82M71.04%1.52B
Public Companies & Retail Investors
91.66M9.40%201.64M
Total
975.25M100.00%2.15B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Eit Oxford Holdings, Llc17.51%170,814,670375,792
IP Group Plc9.00%87,737,695193,023

People Also Watch

310.60
AAF
+0.06%
962.00
IGG
-2.43%
267.60
HBR
-1.98%
464.50
AUTOA
+0.85%
425.70
ENT
+0.38%

FAQ

What Is the Oxford Nanopore (ONT) Stock Price Today?

The Oxford Nanopore stock price today is 234.16 GBP.

What Stock Exchange Does Oxford Nanopore Trade On?

Oxford Nanopore is listed and trades on the London Stock Exchange.

What Is the Stock Symbol for Oxford Nanopore?

The stock symbol for Oxford Nanopore is "ONT."

What Is the Oxford Nanopore Market Cap?

As of today, Oxford Nanopore market cap is 2.15B GBP.

What Is Oxford Nanopore's Earnings Per Share (TTM)?

The Oxford Nanopore EPS (TTM) is -0.13.

When Is the Next Oxford Nanopore Earnings Date?

Oxford Nanopore will release its next earnings report on Mar 09, 2027.

From a Technical Analysis Perspective, Is ONT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Oxford Nanopore Stock Split?

Oxford Nanopore has split 0 times.

How Many Employees Does Oxford Nanopore Have?

Oxford Nanopore has 1314 employees.

What is the current trading status of Oxford Nanopore (ONT)?

As of Oct 06, 2026, Oxford Nanopore (ONT) is trading at a price of 234.16 GBP, with a previous close of 220.00 GBP. The stock has fluctuated within a day range of 219.60 GBP to 238.80 GBP, while its 52-week range spans from 95.70 GBP to 238.80 GBP.

What Is Oxford Nanopore (ONT) Price Target According to Analysts?

The average 12-month price target for Oxford Nanopore is 201.18 GBP, with a high estimate of 300 GBP and a low estimate of 135 GBP. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an -14.08% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.